Signaling pathway profiling using reverse-phase protein array and its clinical applications-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Signaling pathway profiling using reverse-phase protein array and its clinical applications

Published:2017-06-22 Issue:7 Volume:14 Page:607-615
ISSN:1478-9450
Container-title:Expert Review of Proteomics
language:en
Short-container-title:Expert Review of Proteomics

Author:

Masuda Mari¹^ORCID,Yamada Tesshi¹^ORCID

Affiliation:

1. Division of Chemotherapy and Clinical Research, National Cancer Center Research Institute, Tokyo, Japan

Funder

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

National Cancer Center Research and Development Fund

Publisher

Informa UK Limited

Subject

Molecular Biology,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/14789450.2017.1344101

Reference62 articles.

1. Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

2. Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)

3. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

4. Precision medicine for cancer with next-generation functional diagnostics

5. Database of Genomic Biomarkers for Cancer Drugs and Clinical Targetability in Solid Tumors

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parallel Analyses by Mass Spectrometry (MS) and Reverse Phase Protein Array (RPPA) Reveal Complementary Proteomic Profiles in Triple-Negative Breast Cancer (TNBC) Patient Tissues and Cell Cultures;2024-06-03

2. Harnessing the potential of reverse‐phase protein array technology: Advancing precision oncology strategies;Cancer Science;2024-02-26

3. ErbB2_pY_‐1248 as a predictive biomarker for Parkinson's disease based on research with RPPA technology and in vivo verification;CNS Neuroscience & Therapeutics;2023-08-11

4. Efficient Bioinspired Feature Selection and Machine Learning Based Framework Using Omics Data and Biological Knowledge Data Bases in Cancer Clinical Endpoint Prediction;IEEE Access;2023

5. A reverse phase protein array based phospho-antibody characterization approach and its applicability for clinical derived tissue specimens;Scientific Reports;2022-12-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3